The United States and the European Union are using a United Nations High Level Meeting on Non-Communicable Diseases (NCDs) to effectively renegotiate a landmark agreement on intellectual property rights and public health.
Cables mentioning “Special 301” – Context and More Countries – /node/1244
Germany | Embassy Berlin | Feb 23, 2007 | Mission Germany Submission For 2007 Special 301 Review
Ghana | Embassy Accra | Feb 12, 2008 | 2008 Special 301 Review – Ghana
Continue Reading
From KEI staff review of Wikileaks cables (/wikileaks)
From September 19, 2005 to January 15, 2010, the US Department of State sent dozens of cables from Manila reporting on disputes in the Philippines regarding IPR and the pricing of pharmaceutical drugs. Much of the U.S. advocacy in the Philippines was done in close cooperation with Pfizer.
As KEI has discussed previously, USTR’s proposal for the IP chapter of the Trans-Pacific Partnership Agreement (TPPA) raises numerous concerns for human rights, access to medicines, and access to information, among other issues. Continue Reading
The following are 2,446 cables from Wikileaks, that mention the search term: “pharmaceutical.” The search was conducted on August 29, 2011. This is an average of 23 cables per week, for the period. The cables are organized by dates.
On 12 July 2011, the Medicines Patent Pool (MPP) and Gilead announced an agreement for Gilead to license patents for tenofovir (TDF), emtricitabine (FTC), elvitegravir (EVG), cobisistat (COBI) and a four drug combination of these drugs. KEI’s initial comments on the agreement are available here. Continue Reading
On 8 July 2011, the WHO Consultative Expert Working Group on R&D Financing and Coordination (CEWG) held an open session to brief the public on their preliminary assessments and recommendations.
To access the slide presentation presented by the Chair (John Arne Røttingen, Norway) and Vice-Chair (Claudia Inês Chamas, Brazil), please click on the following link: http://www.who.int/phi/news/Open_Session_July_v3.pdf
KEI comment on the Medicines Patent Pool license with Gilead
July 12, 2011
FYI: James Love (Tuesday: +44.785.543.6510, james.love@keionline.org). Thiru Balasubramaniam (thiru@keionline.org) or Krista Cox (krista.cox@keionline.org, +1.202.332.2670).
In response to the WHO Consultative Expert Working Group on R&D Financing’s (CEWG) calls for submissions, 21 proposals were submitted to the CEWG in June 2011 for consideration by the CEWG at their second meeting (7-8 July 2011).
The general link to the WHO CEWG submissions page can be found here: http://www.who.int/phi/news/cewg_submissions/en/index.html
Reproduced below from the WHO CEWG page are links to all the proposals in the order they appear on the WHO page.
Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG)